Bio Fence

Company Overview

Snapshot

Founded in November 2017, Bio Fence operates with 1-10 employees. The company has secured $4.5 million in total capital raised across three funding rounds from three investors. In February 2021, Bio Fence completed an A Round of funding, led by.

Business overview

Bio Fence develops patented antiviral and antimicrobial surface coating technology designed to combat infections spread through contaminated environments. Its core product is a polymer-based solution that can be integrated into plastics, paints, and coatings, enabling surfaces to continuously release biocides over weeks or months. This technology significantly reduces the presence of hazardous pathogens like viruses, Listeria monocytogenes, Salmonella, and Campylobacter, transforming surfaces into active pathogen shields. The company primarily serves industries focused on public safety, food and beverage, and healthcare, operating within the Industrial Technologies sector.

Strategic signal

In February 2021, Bio Fence raised $3.8 million in a financing round, indicating strong investor confidence in its disinfectant technology. This funding signals the company's intent to expand its market reach, particularly into the tourism and aviation sectors, as global recovery from the pandemic progresses. The investment validates the commercial potential of its polymer technology, which can destroy bacteria and viruses on contaminated surfaces over extended periods, positioning Bio Fence for significant growth in infection prevention solutions.

Company Intelligence Q&A

What is Bio Fence's core technology?

Bio Fence has developed a patented technology for antimicrobial and antiviral coating of surfaces. This technology is based on a polymer designed to be incorporated into plastics, paints, and coatings, enabling them to withdraw and stabilize biocides for slow release over weeks.

When did Bio Fence complete its most recent funding round?

In February 2021, Bio Fence completed an A Round of funding, led by.

What markets does Bio Fence plan to enter following its recent funding?

Following its February 2021 financing round, Bio Fence plans to enter the tourism and aviation markets, leveraging its technology to eliminate viruses and bacteria from surfaces as the world recovers from the COVID-19 pandemic.

What was the valuation of Bio Fence during its February 2021 financing round?

In February 2021, Bio Fence completed a $3.8 million financing round at a valuation of $14 million.

What was an early validation of Bio Fence's anti-microbial technology?

In January 2019, Bio Fence successfully completed a field trial for its anti-microbial technology, Pentagon, at a poultry production site in Israel, demonstrating a significant reduction in bacterial presence compared to alternative solutions.